Midurethral sling incision: indications and outcomes by unknown
ORIGINAL ARTICLE
Midurethral sling incision: indications and outcomes
Volker Viereck & Oliver Rautenberg & Jacek Kociszewski &
Susanne Grothey & JoEllen Welter & Jakob Eberhard
Received: 4 April 2012 /Accepted: 8 July 2012 /Published online: 9 August 2012
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract
Introduction and hypothesis Controversy continues over the
effectiveness of sling incision, which is the most common
operative approach to treating complications following subure-
thral sling insertion. This retrospective analysis assessed the
indications for sling incision and patient outcomes regarding
resolution of complications and stress urinary incontinence.
Methods A review was conducted of the medical records of
women who underwent sling incision between 2003 and
2010. Data such as surgical indications, ultrasound findings
and medical outcomes were extracted from 198 records, and
descriptive and inferential statistical methods of analysis
were used.
Results In the 198 patients eligible for study inclusion, the
primary reasons for sling incision were overactive bladder
(68 %), voiding dysfunction (61 %), and recurrent urinary
tract infections (53 %). Additional complications included
dyspareunia (18 %), chronic pelvic pain (17 %), and sling
exposure (15 %). Sling incision led to immediate postoper-
ative cure of voiding dysfunction in 97 % of patients. Cure
rates for overactive bladder and dyspareunia were 60 %
and 94 % respectively. Chronic pelvic pain was resolved
in 82 % of cases and all cases of sling exposure were cured.
Eighty-five (61 %) of the 140 patients who were continent
before sling incision developed recurrent stress urinary
incontinence (SUI) postoperatively.
Conclusions These findings indicate that sling incision can
be highly successful in improving voiding dysfunction and
dyspareunia, and moderately successful in curing overactive
bladder and chronic pain. However, SUI may recur in more
than 60 % of the patients undergoing sling incision. Conse-
quently, patients being considered for a sling incision pro-
cedure should be informed about this possible complication.
Keywords Dystopic sling position . Obstructive and
non-obstructive long-term sling complications . Pelvic floor
ultrasound . Sling incision .Tension-freevaginal tape(TVT) .
Voiding disorders
Introduction
Suburethral sling insertion, tension-free vaginal tape (TVT),
and transobturator tension-free vaginal tape (TVT-O) are
highly successful, minimally invasive alternatives to open
surgery for treating female stress urinary incontinence (SUI)
[1]. Although complications are rare, intraoperative bladder
perforation and postoperative obstructions causing voiding
dysfunction and overactive bladder (OAB) are the most
commonly identified complications [2]. As reported in the
literature, voiding dysfunction occurs in 5–12 % of cases,
and exacerbation or de novo overactive bladder occurs in 3–
25 % of cases [3]. Patients with these complications report
poor urinary flow, staccato voiding, urge symptoms, and
recurrent urinary tract infections (UTI). Less common are
non-obstructive complications such as sling exposure, dys-
pareunia, and chronic pelvic pain in the area of the sling.
The inherent risk of exerting too much tension on the sling
as it is being inserted poses a challenge for physicians as
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they attempt to balance curing the original problem of
incontinence with unintentionally causing postoperative
complications from dystopic or too tightly placed slings.
The time frame in which sling-related complications de-
velop can vary considerably. Some patients experience
symptoms immediately following the procedure; however,
others may develop complications years later. Many women
with complaints related to sling procedures can be treated
conservatively. However, if the problem persists, sling inci-
sion offers the best chance of cure for most patients. Rates of
sling incision procedures reported in the literature range
from 1 to 20 % [4, 5].
To better understand the effectiveness of sling incision in
resolving postoperative complications and treating SUI, we
performed a retrospective analysis of patients who under-
went such a procedure. Our primary aims were to identify
indications for this type of surgical intervention and the
impact of the surgery on resolving complications and the
SUI recurrence rate. In addition, we analyzed the possible
effects of sling position on the occurrence of complications
by using the pelvic floor ultrasound method described in our
previous publications [6, 7], as well as other diagnostic
tools.
Materials and methods
This retrospective analysis includes data obtained from
medical records of women who underwent sling incision at
a tertiary urogynecological center between January 2003
and June 2010. A detailed description of the primary com-
plaint or indication for surgical intervention (i.e., obstructive
and/or irritative bladder symptoms, sling exposure, chronic
pelvic pain, dyspareunia) was obtained from each patient’s
medical records. In all cases, symptoms reported by patients
were verified by urogynecological examinations including
pelvic floor ultrasound and urodynamic testing, which
involved urethrocystoscopy.
Depending on patients’ complaints, supplementary diag-
nostic tests such as urethral calibration with a Charrière 21
to 24 bougie à boule or urethral probing/rotation using a No.
5 to 7 Hegar urethral dilator (Figs. 1, 2) were conducted.
These diagnostic tools are used to determine if the urethral
lumen is being compressed/obstructed by the sling and to
identify the location of the compression. Residual urine
volume was determined either by single catheterization dur-
ing urodynamic or cystoscopic evaluation or by ultrasound.
Voiding dysfunction was defined as abnormally slow and/or
incomplete micturition based on subjective complaints plus
objective assessment of a persistent postmicturition residual
volume of greater than 100 ml.
Using a standardized protocol [8], ultrasound examina-
tions from 2003 until the end of 2009 were performed with a
GE Voluson 730 (GE Healthcare, Chalfont St. Giles, UK)
and with a GE E8 ultrasound device (vaginal scanner, 4.0–
9.0 MHz, 160° beam angle) from the beginning of 2010.
The ultrasound distance between the urethra and suburethral
sling (Fig. 3) was measured using the following parameters
described in our previous publications [6, 7, 9]: urethral
length (UL) was measured on a median sagittal scan with
300-ml bladder filling from the bladder neck to the distal
end of the hypoechogenic urethra (ending at the hyperecho-
genic urethral papilla). The position of the sling (L) along
the urethra (mid-sling as the reference point) was deter-
mined and expressed as a percentage of the entire urethral
length (L/UL). To characterize the proximity of the sling to
the urethra, the shortest distance between the sling and the
longitudinal smooth muscle (LSM) complex of the urethra,
also called the sling–LSM distance, was measured. This was
done by drawing a perpendicular line from the urethral
lumen to the sling.
Following primary diagnostic assessment each patient
received tailored, conservative management of their con-
dition (elimination of infection, local estrogen, physical
therapy or drug treatment). If this initial approach was
insufficient, the option of suburethral sling incision was
discussed with the patient. Patients who were success-
fully treated with conservative management were not
included in this analysis. In order to be eligible for
the study, patients had to have at least one of the six
most commonly reported complications/indications for
sling incision at our center: overactive bladder, voiding
dysfunction, recurrent UTIs, dyspareunia, chronic pelvic
pain and/or sling exposure [10].
Fig. 1 Simple diagnostic tools for supplementary diagnostic evalua-
tion in patients with obstructive complications. Hegar dilators (left;
optimal are Hegar Nos. with diameters of 5 to 7 mm) are used to
demonstrate a stop cock phenomenon as a sign of an excessively tense
sling. A bougie à boule (right; optimal are Charrière Nos. with circum-
ferences of 21.0 to 24.0 mm) is used to identify a sling too close to the
urethra or a penetrating sling
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The sling incision procedure (Fig. 4) was performed with
the patient in the lithotomy position. In patients with sling
exposure, the sling was localized visually and by palpation.
Using information about sling position obtained from pelvic
floor ultrasound, slings close to the urethra were then iden-
tified by intraurethrally palpating the sling edge with a
Charrière 21 to 24 bougie à boule (Figs. 1, 2b). A tight sling
with a stop cock mechanism was identified by withdrawing
and rotating a No. 5 to 7 Hegar dilator through the urethra
(snap mechanism at the site of the sling, Figs. 1, 2a). When
performing the incision in analgosedation (Fig. 4), subure-
thral and periurethral local anesthesia were applied by using
20 ml of 1 % Xylonest (prilocaine hydrochloride) in con-
junction with epinephrine. A short, suburethral, sagittal
incision was made for blunt dissection of the sling with
scissors pulled slightly forward and then completely severed
with a slightly opened clamp placed underneath the sling
(Fig. 4). After complete midline transection of the sling, the
vaginal skin was closed with 3-0 vicryl single-buttress
sutures. In cases of additional sling exposure, not only was
the sling transected at the midline, but the exposed part was
excised. All sling incision procedures were performed by
two experienced urogynecologists. Patients left the operat-
ing room without a catheter and were treated in accordance
with standard postoperative care. Initial attempts to void
were made 2 h after the procedure. A bladder scan (Bladder-
Scan® BVI 6100, Verathon Medical Germany) was done
after spontaneous voiding to measure the residual volume.
Postoperative follow-up visits scheduled at 2-, 6- and 12-
week intervals were done to assess the patient’s condition
regarding complications and SUI. However, for the purpo-
ses of this study the most pivotal visit for determining the
health status of the patients was at 12 weeks. Follow-up
examinations included a history of symptoms, clinical
Fig. 2 Mechanisms of simple
tools for the diagnosis of
obstructive complications.
Hegar dilators Nos. 5 to 7 and
bougies à boule Charrière 21 to
24. a Rotation of the Hegar
dilator during retraction through
the urethra will show a snap
phenomenon if the sling is too
tight, i.e., not tension-free in
patients presenting with signs
of obstructive sling complica-
tions. b Retraction of the bougie
à boule exerting slight pressure
on the posterior urethral wall
will elicit severe pain at the
proximal edge of the sling in
patients with a sling penetrating
the urethral lumen or lying very
close to the lumen
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examination, measurement of residual urine volume, and
pelvic floor ultrasound. SUI was assessed as previously
described by Kociszewski et al. [6, 9] using a combination
of objective and subjective criteria. Specifically, patients
with a negative stress test, a negative 1-h pad test (less than
2 g) and a VAS score of 0–1 at 12 weeks’ follow-up
evaluation were classified as being stress urinary continent.
All other patients were classified as incontinent. Compre-
hensive urodynamic testing was performed only for patients
undergoing incontinence surgery. Because of the recurrent
nature of urinary tract infections, long-term urogynecolog-
ical assessments (≥1 year) including urine cultures were
conducted for patients with this complication.
The study concept was submitted to the local ethics
committee, which waived the need for formal approval as
only routine clinical data were required for analysis (refer-
ence 080605). Descriptive and inferential statistical analyses
were done in SPSS version 19. Non-parametric (Pearson
Chi-squared, Mann–Whitney U, and one sample binomial)
and parametric (Student’s t) tests were conducted using a
significance level of 0.05.
Results
Data were obtained and assessed from 203 women who
underwent sling incision at the tertiary urogynecology unit
during this 8.5-year period. Of these 203 cases, 5 patients
were excluded from the analysis since their sling incision
procedure also included insertion of a new TVT. Therefore,
a total of 198 women were included in this retrospective
review. The majority of the women had the sling insertion
procedure at another institution. However, 95 women un-
derwent TVT™ or TVT-O™ (Ethicon, Somerville, MA,
USA) insertion at our center, which accounts for approxi-
mately 5.6 % (1,696) of the total number of TVT insertion
procedures performed during this time period. The types of
slings most frequently used in all patients were TVT (70 %)
and TVT-O (23 %). The remaining 7 % of the slings were
distributed among Monarc™ (AMS, Minnetonka, MN,
USA), Serasis® (Serag-Wiessner KG, Naila, Germany),
Fig. 3 Ultrasound localization of the sling at rest for diagnosis of a
dystopic sling or dysfunction. a Pelvic floor ultrasound image showing
the optimal position of the tension-free vaginal tape (TVT) b Pelvic
floor ultrasound image showing a TVT positioned too close to the
urethra with excessive tension (sling curling). B bladder, BN bladder
neck, S symphysis; D shortest distance between the sling and the
longitudinal smooth muscle (LSM) complex; UL length of the entire
urethra (bladder neck to urethral papilla) as measured on ultrasound; L
proportion of the urethra (bladder neck to middle of the sling) used to
determine TVT position along the urethra (%)
Fig. 4 Intraoperative site of midurethral sling incision performed with
the patient in the lithotomy position. It is important that the sling is
severed completely since remaining fibers can cause additional com-
plications (i.e., tissue penetration, obstruction). The sling is dissected
suburethrally; the clamp is placed underneath the sling and slightly
opened; the sling is then completely severed with scissors or a scalpel
in between the arms of the clamp
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Safyre (Promedon, Córdoba, Argentina), Sparc™ (AMS),
TVT-Secur™, (Ethicon), and MiniArc (AMS).
The mean age of the women was 64 years (±12; range
36–89 years) and a median weight of 72.8 kg (range, 52–
103) with a median body mass index (BMI) of 26.4 kg/m2
(range, 21–38). The median number of spontaneous deliv-
eries was 2 (range, 0–6). The median interval between the
sling insertion procedure and sling incision was 33 months
(IQR 9–59 months). The mean duration of the surgical
procedure was 19 min (±4; range 8–35 min). The range of
blood loss during surgery was 10 to 90 ml with a median of
45 ml. There were no intra-interventional complications and
post-interventional wound healing was uneventful. The only
type of complication, a small hematoma, developed at the
operative site in 13 patients and resolved spontaneously in
all cases. The median length of hospitalization was 1.4 days
(range 1–5).
All 198 women were seen at the pivotal 12-week follow-
up visit at a mean of 12.2 weeks (±3.0) postoperatively.
However, 10 (5 %) of the patients had incomplete data
(ultrasound results) in their medical records. With regard
to long-term data collection, 159 (80.3 %) women had
additional urogynecological visits 52 weeks (±2) following
the sling incision procedure. The last recorded visit was at a
median of 82.5 weeks (IQR 53–166).
Overactive bladder (68 %), voiding dysfunction (61 %)
and recurrent urinary tract infections (53 %) were the most
frequently experienced complications reported by this study
population. Cases of multiple complications were common
among the women, with a median of two complications per
patient (IQR 2–3 complications). Resolution rates from
these six complications ranged from 60 to 100 %. More
detailed descriptions of the findings for each of these com-
plications are described below.
Voiding dysfunction
Prior to sling incision, 120 women (61 %) had voiding
dysfunction with an average residual urine volume of
210 ml. Sling incision relieved voiding dysfunction with
normalization of residual urine (<100 ml) in 97 % (116)
of these patients within 1–5 days (p<0.0001). Accord-
ing to urodynamic examinations prior to sling incision,
80 % (96) of these 120 women showed a marked
pressure increase at the site of the sling in the urethral
closure pressure profile during coughing (positive pres-
sure transmission ratios at the position of the sling
attributed to urethral obstruction), consistent with a
tonometric stop cock mechanism (Fig. 5) [11]. Probing
with a Hegar dilator (Fig. 2a) revealed a snap phenomenon in
80.8 % (97) of the cases.
A statistically significant difference in the sling–LSM
distance of less than 3 mm was detected between patients
with and without voiding dysfunction (p<0.0001). For
patients with voiding dysfunction, the median sling–
LSM distance was 1.5 mm (IQR .60–2.5) and patients
without voiding dysfunction had a median distance of
3.6 mm (IQR 2.05–5.1; Fig. 6). Of the patients with
voiding dysfunction, the mean sling position was 43.13 %
(±17.1) and those without voiding dysfunction had a mean
position of 46.7 % (±21.5). No statistically significant differ-
ence was identified in the sling positions of these two groups
(p00.208).
Overactive bladder
The most frequently reported complication, overactive blad-
der, was experienced in 134 patients (68 %). OAB symp-
toms were resolved by sling incision in 80 of these 134
women (60 %; p<0.0001). A sling–LSM distance of <3 mm
was not associated with this complication (p00.24).
Recurrent urinary tract infections
The third most commonly reported complication in over
half (104; 53 %) of the women was recurrent urinary
tract infections. Of these 104 patients, 77 (74 %) also
had voiding dysfunction. At 12-week follow-up visits, no
signs or symptoms of UTIs were detected in 86 % of the
patients (89) following sling incision and concomitant
antibiotic therapy (p<0.0001). Of all the patients with
urinary tract infections before sling incision, 87 (84 %)
had a urogynecological visit 52 weeks (±2) following
the sling incision procedure. Nineteen (22 %) of these
Fig. 5 Urethral closure pressure profile (UCPP) during stress in
patients with obstructive sling complications. a Before sling incision:
a dramatic increase in urethral closure pressure during coughing is
apparent at the site of the sling, resulting in continence during stress
and obstructive complications (voiding dysfunction such as staccato
micturition, urinary flow rate reduction, and elevated residual urine). b
Postoperative profile after sling incision: sling incision eliminates the
stop cock phenomenon, which results in normal micturition and resid-
ual urine, but stress urinary incontinence
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women had urinary tract infections at these visits.
When comparing women with and without recurrent
urinary tract infections, statistically significant results
were obtained in those women who had sling–LSM
distances of <3 mm (p00.02). Moreover, no statistically
significant differences in the sling position along the
urethra were found in patients with recurrent urinary
tract infections.
Dyspareunia, chronic pelvic pain, and sling exposure
With regard to dyspareunia, 35 of the 198 women (18 %)
experienced this symptom prior to sling incision. In 24
of these 35 patients (69 %), dyspareunia was due to sling
exposure into the vagina. Of the 11 women with dyspar-
eunia but no exposure, dyspareunia persisted in two
cases. Overall, dyspareunia was resolved after sling inci-
sion in 33 women (94 %; p<0.0001). Chronic pelvic
pain in the area of the sling was reported in 33 of the
198 patients (17 %) before incision. Chronic pelvic pain
was relieved after sling incision in 27 (81 %) of the 33
women (p<0.0001). All 29 exposures were healed fol-
lowing the procedure, which included resection of sling
ends in some patients (p<0.0001). Statistically significant
results were observed in patients with sling exposure.
Patients with a sling–LSM distance <3 mm were less
likely to have sling exposure (p00.004, OR 0.29 [95 %
CI 0.122–0.693]).
Recurrent SUI after sling incision
The stress urinary incontinence rate before sling incision
was 29 % (58 out of 198). Statistically significant results
were observed with a sling–LSM distance >5 mm (p<
0.0001). A total of 141 patients (72 %) were incontinent
after the procedure. Of the 58 women who were incon-
tinent prior to sling incision, 56 remained incontinent and
2 cases were lost to follow-up assessment of SUI status.
In the sub-group that was continent prior to sling incision
(140), 85 or 61 % developed recurrent SUI following the
procedure.
Discussion
Since suburethral sling insertion has emerged as the gold
standard in the surgical treatment of female stress urinary
incontinence [12], effective management strategies for the
associated postoperative complications are becoming more
important [13–15]. A distinction is needed, however, be-
tween the two main types of postoperative complications
occurring after sling procedures—obstructive and non-
obstructive. Obstructive complications (i.e., voiding dys-
function, overactive bladder) are more common and are
encountered in approximately one in seven patients at some
time after sling insertion. Non-obstructive complications
(i.e., sling exposure and fistula formation) are less common,
Fig. 6 A scattergram
summarizes the association of
voiding dysfunction and sling
location: sling distance to
the LSM complex of the urethra
and sling position along the
urethra in patients (n0188)
with and without voiding
dysfunction. Patients with a
sling–LSM distance <3 mm
were more likely to have
voiding dysfunction
(p<0.0001)
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occurring in 1–2 % of women undergoing a sling procedure
[2, 16, 17].
Given the higher incidence of obstructive complications,
researchers have been investigating the causes of complica-
tions, such as the role of the sling position in the develop-
ment of voiding dysfunction. Consistent with other earlier
studies, findings from this retrospective analysis show a
statistically significant difference in the proportion of wom-
en with voiding dysfunction who also had a sling–LSM
distance <3 mm. A distance of the sling of more than
5 mm from the LSM complex was associated with SUI.
Although the importance of the sling location has been
disputed in the literature [7, 9, 18–21], mounting evidence
suggests that too much tension placed on the sling as well as
dystopic sling positioning (i.e., too proximal at the level of
the bladder neck), should be avoided whenever possible.
Our findings indicate that most postoperative complica-
tions can be successfully managed with a sling incision, a
minimally invasive procedure performed under analgoseda-
tion/local anesthesia [22–24]. Despite the apparent benefits
of sling incision in treating postoperative complications, our
results revealed a risk of recurrence of stress urinary incon-
tinence following the procedure in as many as 61 % of the
women, which is higher than previously published rates
(i.e., 21 % by Molden et al.) [25]. The present study is
distinct, however, in that it was conducted with a relatively
large number of patients who had the same procedure (only
midline incision) performed at one center and definitions of
“cured patients” differed.
The shortcomings of our study were the limited data on a
wider array of patient risk factors, and the inability to
compare sling recipients who developed complications and
were treated conservatively with those who had minimally
invasive treatment for postoperative complications. Since
over 50 % of the study patients (103) had sling insertion
procedures at another institution, medical histories for many
of these patients were incomplete. Consequently, data on
preexisting conditions prior to sling insertion, such as OAB
or voiding dysfunction, were not readily available. Yoost et
al. attempted to identify factors that could predict an indi-
vidual patient’s risk of recurrent SUI following sling inci-
sion. The authors found no associations from potential risk
factors such as prior operations, amount of post-void urine
or parity [26].
Additionally, recently published data from a small-scale,
retrospective analysis of 15 patients who underwent a uni-
lateral division of the sling, also known as a “J” cut, indi-
cated that this type of division may carry a lower risk of SUI
recurrence than the midline division [27]. The authors sug-
gest that when the sling is divided unilaterally, support
remains under the urethra and any excess tension is released.
Unpublished data gathered by our institution on 41 women
who underwent a unilateral division showed no significant
differences in outcomes between those women with a mid-
line or unilateral incision. These 41 women were not includ-
ed in this analysis since the study was designed to assess a
homogeneous group with a pure “midline incision” rather
than compare two groups with different interventions. The
lack of published data from a larger scale trial on the impact
of the location of the incision, and the shortcoming of the
above-mentioned study to only include patients with low
bladder capacity limit generalizable conclusions.
In addition, researchers must rely primarily on retrospec-
tive rather than prospective data since the incidence of
complications following sling insertion is relatively low.
Even though outcome data used in this study were collected
prospectively, with the secondary intent of assessing the role
of pelvic floor ultrasound, our study design was largely
retrospective. Despite these limitations, the prospects of a
moderately high risk of recurrence of SUI compared with
the benefits of the sling incision should be taken into ac-
count by both the physician and patient when sling incision
(midline or unilateral) is the primary treatment option.
This risk, however, should not lead a patient to refuse a
sling incision, when advisable, since recurrent incontinence
can be effectively treated with individually tailored pessary
treatment. Pessary treatment is a temporary measure used
during an interval of approximately 3 months until a new
sling procedure can be performed. Pessary treatment is often
well-received by patients, particularly those distressed by
the course of events following the initial procedure, and
some women may even opt for long-term pessary treatment
rather than another sling procedure. A recent study by Ala-
Nissilä et al. demonstrated that the suburethral sling is also a
valid option for women with recurrent SUI and outcomes
are comparable to those of the primary sling procedures
[28]. In another study with a 5-year follow-up period, Palva
et al. found favorable results for repeat TVT procedures in
recurrent SUI. In their study population of 26 women, 75 %
were cured or had markedly improved [29].
In addition to this moderately high risk of SUI recur-
rence, a sling incision ought to be viewed as a reactive
approach to managing postoperative complications. More
proactive and timely strategies are needed to avoid undue
distress in women with complications, especially late devel-
oping ones, which tend to be overlooked and/or their diag-
nosis delayed. As a consequence, the suffering of these
women is prolonged as they undergo inadequate and expen-
sive examinations before the problem can finally be identi-
fied and managed [30].
This raises the question of how to most effectively pre-
vent and/or promptly detect postoperative complications.
One approach is to focus more on practical diagnostic strat-
egies, such as using widely available ultrasound technology
pre- and postoperatively. Useful diagnostic information can
also be obtained with simple tools such as a Hegar dilator or
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a bougie à boule (Figs. 1, 2). These tools are particularly
helpful in detecting the more frequently occurring obstruc-
tive complications, especially those resulting from too tight-
ly placed or dystopic slings. In addition, non-obstructive
sling complications can also be readily detected by ultra-
sound. Given that slings placed too far from the posterior
urethral wall and close to the vaginal skin may cause erosion
or perforation of the vaginal skin resulting in infection,
occult or visible abscesses, and soft tissue infiltration with
fistula formation or ulceration, increasing the physician’s
ability to place the sling within a desirable range ought to
be a priority.
Although sling incisions should not be ruled out as a
means of treating all complications following sling inser-
tion, further research is needed to better understand the
likelihood of SUI recurrence and the risk factors that play
a role in the development of this discouraging and costly
outcome. Moreover, research efforts should be aimed at
exploring ways to decrease the likelihood of developing
postoperative complications, primarily those associated with
too tightly placed or dystopic slings resulting from the
challenge faced by the physician to ensure a cure for stress
incontinence while avoiding inadvertently causing overac-
tive bladder and voiding problems. However, striving to
fully eliminate the incidence of postoperative complications
is unrealistic. Therefore, early detection and treatment of
complications using practical, evidence-based technology
such as pelvic floor ultrasound should be at the forefront
of our efforts.
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